B. Riley Issues Pessimistic Forecast for Aspen Aerogels (NYSE:ASPN) Stock Price

Aspen Aerogels (NYSE:ASPN) had its target price reduced by research analysts at B. Riley from $35.00 to $22.00 in a research note issued to investors on Wednesday,Benzinga reports. The brokerage currently has a “buy” rating on the construction company’s stock. B. Riley’s price target would suggest a potential upside of 170.44% from the company’s previous close. B. Riley also issued estimates for Aspen Aerogels’ Q3 2025 earnings at $0.13 EPS, Q4 2025 earnings at $0.15 EPS, FY2026 earnings at $0.75 EPS and FY2027 earnings at $1.30 EPS.

ASPN has been the subject of several other research reports. Barclays reduced their price target on shares of Aspen Aerogels from $25.00 to $13.00 and set an “overweight” rating for the company in a research report on Wednesday. Craig Hallum cut their price target on shares of Aspen Aerogels from $21.00 to $18.00 and set a “buy” rating for the company in a report on Friday, February 14th. Piper Sandler cut their price target on shares of Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating for the company in a report on Tuesday, October 22nd. Seaport Res Ptn downgraded shares of Aspen Aerogels from a “strong-buy” rating to a “hold” rating in a report on Wednesday, February 12th. Finally, StockNews.com upgraded shares of Aspen Aerogels to a “sell” rating in a report on Wednesday. One analyst has rated the stock with a sell rating, one has given a hold rating and nine have assigned a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $22.44.

Aspen Aerogels Stock Down 2.0 %

ASPN opened at $8.14 on Wednesday. Aspen Aerogels has a twelve month low of $8.02 and a twelve month high of $33.15. The company has a quick ratio of 2.48, a current ratio of 2.93 and a debt-to-equity ratio of 0.27. The company has a 50-day moving average price of $11.85 and a 200 day moving average price of $18.22. The company has a market cap of $667.48 million, a PE ratio of 50.85 and a beta of 2.14.

Aspen Aerogels (NYSE:ASPN) last released its quarterly earnings results on Wednesday, February 12th. The construction company reported $0.15 earnings per share for the quarter, topping the consensus estimate of $0.04 by $0.11. Aspen Aerogels had a net margin of 2.95% and a return on equity of 7.49%. Sell-side analysts expect that Aspen Aerogels will post 0.22 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Aspen Aerogels

A number of hedge funds have recently made changes to their positions in the stock. Millennium Management LLC boosted its position in Aspen Aerogels by 4,757.8% in the 4th quarter. Millennium Management LLC now owns 1,622,022 shares of the construction company’s stock valued at $19,270,000 after buying an additional 1,588,632 shares during the period. Point72 Asset Management L.P. purchased a new position in Aspen Aerogels in the 4th quarter valued at approximately $13,122,000. Alyeska Investment Group L.P. purchased a new position in Aspen Aerogels in the 4th quarter valued at approximately $9,504,000. Dendur Capital LP purchased a new position in Aspen Aerogels in the 4th quarter valued at approximately $9,207,000. Finally, FMR LLC boosted its position in Aspen Aerogels by 23.6% in the 3rd quarter. FMR LLC now owns 4,050,896 shares of the construction company’s stock valued at $112,169,000 after buying an additional 773,647 shares during the period. Hedge funds and other institutional investors own 97.64% of the company’s stock.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.